Clinical Trials Logo

Clinical Trial Summary

This is a phase III study to evaluate the efficacy and safety of ASC(Autologous Adipose-derived Stem Cells) and Fibringlue or Fibringlue in Patients With Crohn's Fistula.


Clinical Trial Description

Experimental: ASC(Autologous Adipose-derived Stem Cells) and Fibringlue, Comparator: Fibringlue, Study type: Interventional, Study design: Randomized ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04612465
Study type Interventional
Source Anterogen Co., Ltd.
Contact KyuJoo Park, MD. Ph D
Phone +82-02-2072-2901
Email kjparkmd@plaza.snu.ac.kr
Status Recruiting
Phase Phase 3
Start date January 9, 2020
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT05742100 - Darvadstrocel for Crohn's Fistula in the Realworld
Completed NCT00992485 - Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula Phase 1
Completed NCT01011244 - Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula Phase 2